Death: Clinical Trials

7 trials for Death, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 terminated. 7 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Terminated 7
Phase 12Terminated 2
Phase 31Terminated 1

Follow Death: new trials by email Literature Review of Death trials Research Report on Death

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II
SB-913 - Mucopolysaccharidosis II, MPS II
Phase 1 / Phase 2TerminatedSangamo Therapeutics92017-05-112022-10-25
Cooling to Optimize Organ Life in Donor Study
Cold isotonic fluid and central venous hypothermia catheter - Organ Transplantation From Brain-dead Donors
Phase 2TerminatedUniversity of Pittsburgh42012-03-012018-02-07
Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis
99mTc-NC100692 - Hypertrophic Cardiomyopathy, Acute Coronary Syndrome
Phase 2TerminatedOttawa Heart Institute Research Corporation1202011-05-012017-04-24
Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders
hematopoietic stem cell infusion - Hurler Syndrome (MPS I), Hurler-Scheie Syndrome
Phase 1 / Phase 2TerminatedTalaris Therapeutics Inc.32011-04-012023-04-12
Clinical Trial of Growth Hormone in MPS I, II, and VI
Somatropin (DNA origin) - Mucopolysaccharidosis I, Mucopolysaccharidosis II
Phase 2 / Phase 3TerminatedLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center22008-11-012018-09-05
Fetal Tracheal Balloon Study in Diaphragmatic Hernia
Fetal tracheal obstruction with detachable balloon (device) - Diaphragmatic Hernia, Lung Disease
Phase 2TerminatedRhode Island Hospital32008-09-012017-05-30
Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial
Epinephrine, Metoprolol - Cardiac Arrest, Sudden Cardiac Death
Phase 2TerminatedDavid Haines, MD72007-01-012017-05-25

Narrower conditions

Mucopolysaccharidosis II (3)  ·  Sudden Infant Death (3)  ·  Mucopolysaccharidosis I (2)  ·  Acute Coronary Syndrome (1)  ·  Adrenoleukodystrophy (1)  ·  Brain Death (1)  ·  Cardiomyopathy, Hypertrophic (1)  ·  Death, Sudden (1)  ·  Death, Sudden, Cardiac (1)  ·  Dwarfism (1)  ·  Heart Arrest (1)  ·  Hernia, Diaphragmatic (1)  ·  Leukodystrophy, Globoid Cell (1)  ·  Leukodystrophy, Metachromatic (1)  ·  Lung Diseases (1)

Broader conditions

Pathologic Processes (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Death, Sudden (4)  ·  Nervous System Diseases (4)  ·  Neurobehavioral Manifestations (4)  ·  Neurologic Manifestations (4)  ·  Carbohydrate Metabolism, Inborn Errors (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Connective Tissue Diseases (3)  ·  Genetic Diseases, Inborn (3)  ·  Genetic Diseases, X-Linked (3)  ·  Heredodegenerative Disorders, Nervous System (3)  ·  Infant Death (3)  ·  Intellectual Disability (3)

Interventions

Epinephrine (1)  ·  Growth Hormone (1)  ·  Human Growth Hormone (1)  ·  Metoprolol (1)  ·  Stem Cell Transplantation (1)  ·  technetium 99m NC 100692 (1)

Sponsors

David Haines, MD (1)  ·  Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1)  ·  Ottawa Heart Institute Research Corporation (1)  ·  Rhode Island Hospital (1)  ·  Sangamo Therapeutics (1)  ·  Talaris Therapeutics Inc. (1)  ·  University of Pittsburgh (1)

Countries

United States (6)  ·  Canada (1)

Top investigators

David E Haines, MD (1)  ·  Francois I Luks, MD, PhD (1)  ·  Lynda E Polgreen, M.D. (1)  ·  Suzanne T Ildstad, MD (1)  ·  Terrence Ruddy, MD (1)

Results publications

PMID 36299240